What we do Procter & Gamble Health Ltd manufactures and markets pharmaceuticals and chemicals, focusing on vitamin formulations, prescription drugs, and consumer health products in India. |
Founded in 1,967 |
Market share A leading player in the Indian vitamin and consumer health segment with strong brands like Neurobion and Evion. |
Problem solved Addresses vitamin deficiencies, neuropathy, anemia, and lifestyle diseases with quality healthcare and pharmaceutical products. |
Top clients or who we serve Serves consumers, healthcare professionals, and retail customers largely in India, with B2C and B2B business models. |
Key management - |
Our journey and innovations Founded in 1967, underwent name changes culminating in its current brand in 2019, expanded product range and manufacturing capacities over decades. |
Where we operate Primarily India with domestic and export operations to selected international markets. |
Top products or what we offer Vitamins, minerals, supplements, prescription drugs, and consumer healthcare products including Neurobion, Evion, Polybion, Livogen, Nasivion. |
Top brands Neurobion (#1 nerve health supplement), Evion (Vitamin E category leader), Livogen (iron supplements), Polybion (B-complex syrups), Nasivion (nasal decongestants). |
Raw materials needed Pharmaceutical chemicals, bulk drugs, pigments, active pharmaceutical ingredients. |
Raw materials supplier Global suppliers including parent network and specialized chemical producers. |
Recurring vs cyclical contribution Revenue is largely recurring driven by pharmaceutical and consumer health product sales. |
Our industry position Strong market presence as a top vitamin and consumer healthcare brand in India with consistent growth. |
Financial highlights FY 2024-25 revenue Rs 934 Crores with PAT Rs 234 Crores; strong 8% sales and 27% profit growth over comparable period. |
Geographical revenue split Approximately 93% domestic revenue and 7% export revenue as of FY 2024-25. |
Order book - |
Whats driving growth Demand for vitamins, increased health awareness, digital and e-commerce growth, innovative product launches, brand strength. |
Our future plans Focus on expanding portfolio, enhancing digital presence, increasing rural reach, and sustainability initiatives. |
Our green promise Zero manufacturing waste landfill site, green house gas reduction targets, compliance with plastic waste regulations. |
Our people and values 1,326 employees; culture focused on growth mindset, diversity, and ethical compliance. |
Key challenges ahead Regulatory risks, pricing controls, economic uncertainties, supply chain dependencies, competitive pressures. |
Interesting facts Part of global Merck KGaA group; pioneered vitamin formulations in India; launched India’s first patient recovery guidelines. |
Risks and strategy Proactively manages regulatory changes and market risks via strong compliance, risk management, and operational excellence. |
